Strand Therapeutics

News

Recent financings in biotech include a $153m Series B for programmable mRNA developer Strand, plus rounds for Artbio, Minghui, and Chai Discovery.

News

MSD has been rocked by a court judgment ordering it to stop making and selling subcutaneous Keytruda in eight European markets.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.